ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System
Device Facts
| Record ID | K223735 |
|---|---|
| Device Name | ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System |
| Applicant | Siemens Medical Solutions USA, Inc. |
| Product Code | IYN · Radiology |
| Decision Date | Feb 6, 2023 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 892.1550 |
| Device Class | Class 2 |
| Attributes | Pediatric |
Indications for Use
The ACUSON Sequoia and Sequoia Select ultrasound imaging system is intended to provide images of, or signals from, inside the body by an appropriately trained healthcare professional in a clinical setting for the following applications: Fetal, Abdominal, Pediatric, Neonatal Cephalic, Small Parts, OB/GYN (useful for visualization of the ovaries, follicles, uterus and other pelvic structures), Cardiac, Pelvic, Vascular, Musculosketal and Peripheral Vascular applications. The system supports the Ultrasonically-Derived Fat Fraction (UDFF) measurement tool to report an index that can be useful as an aid to a physician managing adult patients with hepatic steatosis. The system also provides the ability to measure anatomical structures for fetal, abdominal, pediatric, small organ, cardiac, transrectal, transvaginal, peripheral vessel, musculoskeletal and calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
Device Story
Mobile, software-controlled diagnostic ultrasound system; transmits/receives ultrasound echo data; displays images in multiple modes (B-Mode, Doppler, M-mode, Elastography, 3D/4D, etc.). Operated by trained healthcare professionals in clinical settings. Provides anatomical measurements and UDFF index for hepatic steatosis management. Output viewed on integrated display; used adjunctively with other clinical data for diagnosis. Benefits include non-invasive visualization and quantitative assessment of tissue/structures.
Clinical Evidence
No clinical data. Substantial equivalence supported by bench testing, including acoustic output, biocompatibility (ISO 10993-1), and electrical/mechanical safety (IEC 60601 series).
Technological Characteristics
Mobile ultrasound system; 1.0-18 MHz frequency range. Patient contact materials tested to ISO 10993-1. Compliance with IEC 60601-1, IEC 60601-2-37, and IEC 62359. Features include 23.8" OLED monitor, 13.3" touch screen, and various imaging modes (B, M, Doppler, Elastography, 3D/4D).
Indications for Use
Indicated for fetal, abdominal, pediatric, neonatal/adult cephalic, small parts, OB/GYN, cardiac, pelvic, vascular, musculoskeletal, and peripheral vascular imaging in adult and pediatric patients. Supports UDFF measurement for hepatic steatosis management in adults.
Regulatory Classification
Identification
An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
Predicate Devices
- ACUSON Sequoia (K221500)
Submission Summary (Full Text)
{0}------------------------------------------------
February 6, 2023
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Siemens Medical Solutions USA, Inc. % Sulgue Choi Regulatory Affairs Manager 22010 South East 51st Street ISSAQUAH WA 98029
# Re: K223735
Trade/Device Name: ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: Class II Product Code: IYN, IYO, ITX, OIJ Dated: December 13, 2022 Received: January 12, 2023
# Dear Sulgue Choi:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
{1}------------------------------------------------
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
# Yanna S. Kang -S
Yanna Kang, Ph.D. Assistant Director Mammography and Ultrasound Team DHT8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
### 510(k) Number (if known) K223735
#### Device Name
ACUSON Sequoia Diagnostic Ultrasound System ACUSON Sequoia Select Diagnostic Ultrasound System
### Indications for Use (Describe)
The ACUSON Sequoia and Sequoia Select ultrasound imaging system is intended to provide images of, or signals from, inside the body by an appropriately trained healthcare professional in a clinical setting for the following applications: Fetal, Abdominal, Pediatric, Neonatal Cephalic, Small Parts, OB/GYN (useful for visualization of the ovaries, follicles, uterus and other pelvic structures), Cardiac, Pelvic, Vascular, Musculosketal and Peripheral Vascular applications.
The system supports the Ultrasonically-Derived Fat Fraction (UDFF) measurement tool to report an index that can be useful as an aid to a physician managing adult patients with hepatic steatosis.
The system also provides the ability to measure anatomical structures for fetal, abdominal, pediatric, small organ, cardiac, transrectal, transvaginal, peripheral vessel, musculoskeletal and calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
### Operating Modes
2D-mode
- 2D-mode .
- o 2D-mode with Harmonics Imaging
- . 2D-mode with Harmonics Imaging for Contrast Agent Imaging
- 3D/4D Volume Imaging
Color flow Doppler
- . Color (velocity)
- Power (energy) .
Doppler
- Pulsed Wave Doppler ●
- Pulsed Wave Doppler Tissue Imaging
- . High Pulsed Repetition Frequency Pulsed Wave Doppler
- Steerable Continuous Wave Doppler for imaging transducers
- Continuous Wave Doppler for non-imaging transducers
### M-mode
- M-mode with Harmonics Imaging .
- Anatomical M-Mode
Elastography
- Strain Imaging .
- . Shear Wave Elastography
Combined Modes
2D-mode with color 2D-mode with Doppler 2D-mode with color and Doppler 2D-mode with M-mode 2D-mode with M-mode and Color 2D-mode with Elastography
{3}------------------------------------------------
| 3D/4D Volume Imaging with color |
|---------------------------------|
|---------------------------------|
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{4}------------------------------------------------
### 510(k) Summary
# K223735
| Date: | January 11, 2023 | | | | | | | | | | | | |
|------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------|----------|--------|---------------------------------------|----------|--------|----------------------------------|----------|--------|-------------------------|----------|--------|
| 1. Sponsor: | Siemens Medical Solutions USA, Inc.<br>Ultrasound Division<br>22010 South East 51st Street<br>Issaquah, Washington 98029 | | | | | | | | | | | | |
| Contact Person: | Sulgue Choi<br>Tel: (425) 281-9898 | | | | | | | | | | | | |
| 2. Device Name: | ACUSON Sequoia Diagnostic Ultrasound System<br>ACUSON Sequoia Select Diagnostic Ultrasound System | | | | | | | | | | | | |
| Common Name: | Diagnostic Ultrasound System with Accessories | | | | | | | | | | | | |
| Classification: | Regulatory Class: II<br>Review Category: Tier II<br>Classification Panel: Radiology | | | | | | | | | | | | |
| | <table><tr><td>Ultrasonic Pulsed Doppler Imaging System</td><td>892.1550</td><td>90-IYN</td></tr><tr><td>Ultrasonic Pulsed Echo Imaging System</td><td>892.1560</td><td>90-IYO</td></tr><tr><td>Diagnostic Ultrasound Transducer</td><td>892.1570</td><td>90-ITX</td></tr><tr><td>Biopsy Needle Guide Kit</td><td>892.1560</td><td>90-OIJ</td></tr></table> | Ultrasonic Pulsed Doppler Imaging System | 892.1550 | 90-IYN | Ultrasonic Pulsed Echo Imaging System | 892.1560 | 90-IYO | Diagnostic Ultrasound Transducer | 892.1570 | 90-ITX | Biopsy Needle Guide Kit | 892.1560 | 90-OIJ |
| Ultrasonic Pulsed Doppler Imaging System | 892.1550 | 90-IYN | | | | | | | | | | | |
| Ultrasonic Pulsed Echo Imaging System | 892.1560 | 90-IYO | | | | | | | | | | | |
| Diagnostic Ultrasound Transducer | 892.1570 | 90-ITX | | | | | | | | | | | |
| Biopsy Needle Guide Kit | 892.1560 | 90-OIJ | | | | | | | | | | | |
| Manufacturing Site: | Siemens Medical Solutions USA, Inc.<br>22010 South East 51st Street,<br>Issaquah, Washington 98029, UNITED STATES | | | | | | | | | | | | |
### 3. Legally Marketed Predicate Devices
The ACUSON Sequoia and Sequoia Select Diagnostic Ultrasound Systems are a multi-purpose diagnostic ultrasound system with accessories and proprietary software, and is substantially equivalent to the company's own products, the ACUSON Sequoia (K221500) which is primary predicated device.
- -Primary Predicate Device: ACUSON Sequoia (K221500)
{5}------------------------------------------------
# 4. Device Description
The ACUSON Sequoia and Sequoia Select Diagnostic Ultrasound Systems are a multi-purpose mobile, software controlled, diagnostic ultrasound system with an on-screen display of thermal and mechanical indices related to potential bio-effect mechanisms. Its function is to transmit and receive ultrasound echo data and display it in B-Mode, Pulsed (PW) Doppler Mode, Continuous (CW) Doppler Mode, Color Doppler Mode, Color M Mode, Doppler Tissue Mode, Amplitude Doppler Mode, a combination of modes, Panoramic Imaging, Contrast agent Imaging, Virtual Touch Strain Imaging, Virtual Touch - pSWE Imaging, Virtual Touch - SWE Imaging, syngo Velocity Vector Imaging, Custom Tissue Imaging, 3D/4D Volume Imaging and Harmonic Imaging on a Display.
# 5. Intended Use/Indications for Use
The ACUSON Sequoia and Sequoia Select ultrasound imaging system is intended to provide images of, or signals from, inside the body by an appropriately trained healthcare professional in a clinical setting for the following applications: Fetal. Abdominal. Pediatric. Neonatal Cephalic. Small Parts, OB/GYN (useful for visualization of the ovaries, follicles, uterus and other pelvic structures), Cardiac, Pelvic, Vascular, Adult Cephalic, Musculoskeletal and Peripheral Vascular applications.
The system supports the Ultrasonically-Derived Fat Fraction (UDFF) measurement tool to report an index that can be useful as an aid to a physician manaqing adult patients with hepatic steatosis.
The system also provides the ability to measure anatomical structures for fetal, abdominal, pediatric, small organ, cardiac, transvaqinal, peripheral vessel, musculoskeletal and calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
### Operating Modes
2D-mode
- 2D-mode .
- 2D-mode with Harmonics Imaging
- . 2D-mode with Harmonics Imaging for Contrast Agent Imaging
- 3D/4D Volume Imaging
- Color flow Doppler
- Color (velocity) .
- . Power (energy)
Doppler
- Pulsed Wave Doppler .
- Pulsed Wave Doppler Tissue Imaging •
- High Pulsed Repetition Frequency Pulsed Wave Doppler .
- . Steerable Continuous Wave Doppler for imaging transducers
- . Continuous Wave Doppler for non-imaging transducers
M-mode
- M-mode with Harmonics Imaging .
- . Anatomical M-Mode
- Elastography
- . Strain Imaging
{6}------------------------------------------------
- . Shear Wave Elastography
Combined Modes 2D-mode with color 2D-mode with Doppler 2D-mode with color and Doppler 2D-mode with M-mode 2D-mode with M-mode and Color 2D-mode with Elastography 3D/4D Volume Imaging with color
### 6. Summary of Technological Characteristics
The modified ACUSON Sequoia and Sequoia Select Ultrasound Systems are the same as the company's own previously cleared ACUSON Sequoia (K221500) with regard to both intended use and technological characteristics. Both the modified ultrasound system under this review and the predicate ultrasound systems function in the same manner as all diagnostic ultrasound systems and transducers.
The submission device differs from the predicated devices as following:
- -Software feature
- . The modified ACUSON Sequoia Ultrasound System includes the expansion of the UDFF (Ultrasonically-Derived fat fraction) software features for 5C1 transducer which were already cleared on the ACUSON Sequoia (K221500)
- Transducer & Accessories -
- The addition of needle quide kit, 10EV3, which is substantially equivalent to the ● needle quide Kit, 9EC4 previously cleared on the ACUSON Sequoia (K221500)
- Hardware change and improvement -
- . New monitor and monitor arm
- . Common Control Panel and Control Panel cradle
- . Update rear storage basket
The foundation of the ACUSON Sequoia and Sequoia Select (this submission) are the ACUSON Sequoia(K221500) with features and transducers integrated with the ACUSON Sequoia(K221500) hardware and the ACUSON Sequoia Select(this submission) reuse software developed for Sequoia(K221500) mainly. All other hardware and software features of the ACUSON Sequoia and Sequoia Select Diagnostic Ultrasound devices remain unchanged.
The submission devices are substantially equivalent to the predicate with regards to both intended use and technological characteristics.
{7}------------------------------------------------
### ACUSON Sequoia & Sequoia Select Diagnostic Ultrasound System Special 510(k) Submission
| Feature / Characteristic | ACUSON Sequoia<br>This Submission | ACUSON Sequoia<br>Select<br>This Submission | ACUSON Sequoia<br>K# 221500<br>Predicate device | |
|--------------------------------------------------------------|------------------------------------------------------|------------------------------------------------------|-------------------------------------------------|----------------|
| | Indications for Use: | | | |
| ■ | Fetal | √ | √ | √ |
| ■ | Abdominal | √ | √ | √ |
| ■ | Pediatric | √ | √ | √ |
| ■ | Small Organ | √ | √ | √ |
| ■ | Cardiac | √ | √ | √ |
| ■ | Transrectal | √ | √ | √ |
| ■ | Transvaginal | √ | √ | √ |
| ■ | Peripheral vessel | √ | √ | √ |
| ■ | Musculo-skeletal<br>(conventional) | √ | √ | √ |
| ■ | Musculo-skeletal<br>(superficial) | √ | √ | √ |
| ■ | Neonatal cephalic | √ | √ | √ |
| ■ | Adult cephalic | √ | √ | √ |
| | Frequencies Supported: | (1.0MHZ~18MHz) | (1.0MHZ~18MHz) | (1.0MHZ~18MHz) |
| | Modes: | | | |
| ■ | B | √ | √ | √ |
| ■ | M | √ | √ | √ |
| ■ | PWD (Pulsed Wave<br>Doppler) | √ | √ | √ |
| ■ | CWD (Continuous Wave<br>Doppler) | √ | √ | √ |
| ■ | PW DTI (Doppler Tissue<br>Image) | √ | √ | √ |
| ■ | Color Doppler | √ | √ | √ |
| ■ | Power Doppler | √ | √ | √ |
| ■ | Combined (BMDC) | √ | √ | √ |
| | Features: | | | |
| ■ | Harmonic imaging | √ | √ | √ |
| ■ | Panoramic imaging | √ | √ | √ |
| ■ | Color Panoramic<br>imaging | √ | √ | √ |
| ■ | Auto TEQ | √ | √ | √ |
| ■ | Cardiac Imaging<br>physiological signal<br>display | √ | √ | √ |
| ■ | eSie OB | √ | √ | √ |
| ■ | Compounding | √ | √ | √ |
| ■ | Contrast imaging | √ | √ | √ |
| Feature / Characteristic | ACUSON Sequoia<br>This Submission | ACUSON Sequoia<br>Select<br>This Submission | ACUSON Sequoia<br>K# 221500<br>Predicate device | |
| Clarify | √ | √ | √ | |
| Virtual Touch - Strain<br>syngo ® Velocity Vector<br>Imaging | √ | √ | √ | |
| eSie Calc | √ | √ | √ | |
| Speed of Sound | √ | √ | √ | |
| Fusion | √ | √ | √ | |
| Virtual Touch – pSWE | √ | √ | √ | |
| Virtual Touch – SWE | √ | √ | √ | |
| UltraArt | √ | √ | √ | |
| Modality Compare | √ | √ | √ | |
| HD Zoom | √ | √ | √ | |
| Protocols | √ | √ | √ | |
| InFocus | √ | √ | √ | |
| Flash sequencing | √ | √ | √ | |
| Gesture control | √ | √ | √ | |
| TeamViewer | √ | √ | √ | |
| Motion Stabilized<br>Persistence | √ | √ | √ | |
| DICOM | √ | √ | √ | |
| DICOM SR | √ | √ | √ | |
| Slow Flow Color Doppler<br>State | √ | √ | √ | |
| Dynamic MultiHertz | √ | √ | √ | |
| 3D/4D Volume Imaging<br>Mode | √ | √ | √ | |
| UDFF (Ultrasonically-<br>Derived Fat Fraction) | √ | √ | √ | |
| Auto pSWE | √ | √ | √ | |
| Auto IMT | √ | √ | √ | |
| eSieDoppler | √ | √ | √ | |
| Virtual workstation | √ | √ | √ | |
| Velocity Variance<br>Mapping | √ | √ | √ | |
| Feature / Characteristic | ACUSON Sequoia<br>This Submission | ACUSON Sequoia<br>Select<br>This Submission | ACUSON Sequoia<br>K# 221500<br>Predicate device | |
| Monitor: 21" FPD<br>(OLED) | √<br>(23.8" Dual Layer<br>High Dynamic Range<br>FPD) | √<br>(23.8" Dual Layer<br>High Dynamic Range<br>FPD) | √ | |
| Touch Screen: 15"<br>adjustable Touch<br>Screen | √<br>(13.3" adjustable<br>touch screen) | √<br>(13.3" adjustable<br>touch screen) | √ | |
| Output Display<br>Standard (Track 3) | √ | √ | √ | |
| Patient Contact Materials | Tested to ISO<br>10993-1 | Tested to ISO<br>10993-1 | Tested to ISO<br>10993-1 | |
| UL 60601-1 Certified | √ | √ | √ | |
| Indications for Use | √ | √ | √ | |
{8}------------------------------------------------
### ACUSON Sequoia & Sequoia Select Diagnostic Ultrasound System Special 510(k) Submission
{9}------------------------------------------------
### 7. A brief discussion of nonclinical tests submitted, referenced, or relied on in the 510(k) for a determination of substantial equivalence
The devices have been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic and mechanical safety and have been found to conform to applicable medical device safety standards. The systems comply with the following voluntary standards:
- I IEC 62359: Edition 2.1 2017-09, Ultrasonics - Field characterization - Test methods for the determination of thermal and mechanical indices related to medical diagnostic ultrasonic fields / Combines IEC 62359 (2010-10) and AMD 1 (2017-09)
- I Safety and EMC Requirements for Medical Equipment
- AAMI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and o A2:2010/(R)2012 (Consolidated Text) Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005)
- IEC 60601-1:2005/A1(2012), Medical electric equipment Part 1: General O requirements for basic safety and essential performance / This document and its separate amendments continue to be valid together with the consolidated version
- IEC 60601-1-2 Edition 4.0 2014-02, Medical electrical equipment Part 1-2: O General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests
- IEC 60601-2-18: Edition 3.0 2009-08, Medical electrical equipment Part 2-18: O Particular requirements for the basic safety and essential performance of endoscopic equipment
- IEC 60601-2-37 Edition 2.1 2015. Medical electrical equipment Part 2-37: O Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment
- I ISO 10993-1 Fifth edition 2018-08, Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
{10}------------------------------------------------
### 8. A summary discussion of the clinical tests submitted, referenced, or relied on for a determination of substantial equivalence.
Since the ACUSON Sequoia and Sequoia Select Diagnostic Ultrasound Systems use the same technology and principles as existing devices, clinical studies were not required to support substantial equivalence.
### 9. Summary
Intended uses and other key features are consistent with traditional clinical practice and FDA guidelines. The design and development process of the manufacturer conforms to 21 CFR 820 Quality System Regulation and ISO 13485:2016 quality system standards. The product is designed to conform to applicable medical device safety standards and compliance is verified through independent evaluation with ongoing factory surveillance. Diagnostic ultrasound system has accumulated a long history of safe and effective performance. Therefore, it is the opinion of Siemens Medical Solutions USA, Inc. that the ACUSON Sequoia and Sequoia Select systems are substantially equivalent with respect to safety and effectiveness to devices currently cleared for market.
